Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected
about
Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected
description
clinical trial
@en
klinisch onderzoek
@nl
name
Safety and Efficacy of Switchi ...... ally Suppressed HIV-1 Infected
@en
type
label
Safety and Efficacy of Switchi ...... ally Suppressed HIV-1 Infected
@en
prefLabel
Safety and Efficacy of Switchi ...... ally Suppressed HIV-1 Infected
@en
P17
P131
P1476
A Phase 3, Randomized, Open-La ...... ppressed HIV-1 Infected Adults
@en
P17
P3098
NCT02603107
P580
2015-11-20T00:00:00Z
P582
2017-05-15T00:00:00Z